Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Kariminejad - |
RCV001814538 | SCV001755571 | pathogenic | Abnormality of the skin | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV002568934 | SCV002009230 | likely pathogenic | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV002290718 | SCV002579889 | likely pathogenic | Tyrosinase-negative oculocutaneous albinism | 2022-05-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002568934 | SCV003440463 | pathogenic | not provided | 2024-11-11 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 332 of the TYR protein (p.Met332Ile). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with ocular albinism and/or oculocutaneous albinism type 1 (PMID: 19060277, 25216246, 26167114, 30472657). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 1180809). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt TYR protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003470858 | SCV004207544 | pathogenic | SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN | 2023-12-21 | criteria provided, single submitter | clinical testing |